Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. After all, clinical trials are designed to establish the safety and efficacy of drugs: a pharmacist’s specialty.
However, pharmacists are rarely consulted in clinical trials. To remedy this issue, Founder and CEO Gerald Finken created RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, offering primary stakeholders their rightful seat at the clinical research table.
“I sometimes think that’s the catalyst that separated it—why pharmacists don’t have a role in the industry today. Pharmacists went the way of community, and the formulation scientists went hardcore science into development,” Finken tells Deborah Borfitz, Clinical Research News senior writer and host of the Scope of Things podcast. As a result, each sub-specialty moved into more clearly defined and independent roles, slowly and surely leaving clinical research behind.
